In a groundbreaking study published in BMC Cancer, researchers have unveiled a p...
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detec...
Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year a...
Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at alm...
Genentech has announced an investment exceeding $700m to establish its first Eas...
The new OS results came from the Phase III INAVO120 study evaluating an Itovebi ...
The NICE has issued final draft guidance endorsing the use of CSL Vifor's Filspa...
The Trump administration’s budget reconciliation bill has passed the US House of...
An EMA committee has issued a positive opinion for a label extension that would ...
GSK has received approval from the US Food and Drug Administration (FDA) for its...
In the intricate and bustling environment of a cell, microscopic highways called...
In an era where precision medicine increasingly shapes cancer treatment, the abi...
The realm of two-dimensional (2D) materials has long held promise for revolution...
In a breakthrough study that could reshape therapeutic approaches to one of the ...
In early childhood education settings across Japan, the architectural design of ...